Abstract
This article examines the transformative potential of blockchain technology and its integration with artificial intelligence (AI) in clinical trials, focusing on their combined ability to enhance integrity, operational efficiency, and transparency in the data governance. Through an in-depth analysis of recent advancements, the article highlights how blockchain and AI address critical challenges, including patient data privacy, regulatory compliance, and security. The article also identifies key barriers to adoption in the mentioned integration, such as scalability limitations, association with existing healthcare systems, and high implementation costs. By presenting a comprehensive overview of the current research and proposing strategic directions, this work emphasizes how the synergy between blockchain and AI can revolutionize clinical trials through process automation, improved stakeholder trust, and robust transparency.